AMANTADINE FOR DYSKINESIA TARDA

被引:0
|
作者
VALE, S
ESPEJEL, MA
机构
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1971年 / 284卷 / 12期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:673 / &
相关论文
共 50 条
  • [23] Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
    Santiago Perez-Lloret
    Olivier Rascol
    Journal of Neural Transmission, 2018, 125 : 1237 - 1250
  • [24] Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine A Case Report
    Kusudo, Keisuke
    Uchida, Hiroyuki
    Okada, Yuki
    Yoshida, Kazunari
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 424 - 425
  • [25] Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia
    Perez-Lloret, Santiago
    Rascol, Olivier
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (08) : 1237 - 1250
  • [26] Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia
    Brigham, Elizabeth F.
    Johnston, Tom H.
    Brown, Carl
    Holt, Jonathon D. S.
    Fox, Susan H.
    Hill, Michael P.
    Howson, Patrick A.
    Brotchie, Jonathan M.
    Nguyen, Jack T.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 367 (02): : 373 - 381
  • [28] Extended-Release Amantadine (Gocovri) for Dyskinesia in Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 198 - 200
  • [29] A multicenter randomized control trial of amantadine for dyskinesia in Parkinson's disease
    Sawada, H.
    Oeda, T.
    Kuno, S.
    Nomoto, M.
    Yamamoto, K.
    MOVEMENT DISORDERS, 2009, 24 : S277 - S277
  • [30] New use for an old drug: Amantadine benefits levodopa-induced dyskinesia
    Rajput, AH
    Rajput, A
    Lang, AE
    Kumar, R
    Uitti, RJ
    Galvez-Jimenez, N
    MOVEMENT DISORDERS, 1998, 13 (05) : 851 - 851